Share via Shortlink Photo illustration of Knotel CEO Amol Sarva (Sarva by Sasha Maslov; iStock)As Knotel battles lawsuits from landlords, evictions and accusations of unpaid rent, its CEO says the flex-office provider has secured new funding.Knotel CEO Amol Sarva reportedly told staff on Monday that the company has gotten a fresh influx of cash, according to Business Insider, citing a source with knowledge of the all-hands meeting.Sarva did not disclose the amount of money raised or details about who was involved, although a source told the publication that it is a restructuring type of deal that includes equity and debt.Earlier this summer, Sarva said he had raised $10 million and wanted to raise $100 million by the end of August. Forbes reported that the new funding could cut the company’s valuation in half.In August 2019 the company said it raised $400 million through a Series C raise, which gave Knotel a valuation of at least $1.3 billion. Investors included Mori Trust, Itochu Corp, and Mercuria Investment Co, along with Newmark Knight Frank, Norwest Venture Partners, and the Sapir Organization, which is led by Alex Sapir.This year, Knotel has suffered along with other co-working companies as demand for office space has lagged during the pandemic. The company has been hit with a dozens of lawsuits over the past few months from landlords who claim they have not been paid, as well as eviction notices at two of its spaces.Knotel has also been scaling back its once-ambitious expansion plans and in November said it was looking to trim 60 percent of its 4.8 million-square-foot global portfolio. It has also cut staff several times over the course of the pandemic.[Business Insider] — Keith Larsen Share on FacebookShare on TwitterShare on LinkedinShare via Email Share via Shortlink TagsCommercial Real EstateKnoteloffice marketReal Estate Lawsuits
cold store is now doing a good project, this project a lot of advantages, in recent years, with the rapid increase of China’s economy, now people’s consumption view has also changed, various industries have entered the sales boom, including the sales of cold drinks add the fastest, the following will provide you with the introduce of cold store the prospect of market.
1, tourism heat. What are the market prospects for a cold drink shop? In the people’s food and clothing problems, people have gone out to look at the outside world, so the interpretation of a tourism golden week hot situation;
2, the purchase of hot, after watching the outside world still have to return home, so people want to improve their own housing, which led to high prices steadily.
3, diet, pocket money, people entertain guests, friends gathering is no longer busy at home, but a meal to the restaurant. But with lavish meals to eat for a long time, people are tired, so we are now entering the era of diet. What are the market prospects for a cold drink shop? After the era of the diet is characterized by: "drink" is no longer confined to drinking water, but also to drink wine, drink a cold drink, drink coffee. Food gradually tends to light, clear mouth.
cold drinks store market prospects are very broad. More and more casual food culture, more casual, no longer luxury, high, but emphasis on features, characteristics and taste. What are the market prospects for a cold drink shop? In the regional characteristics of diet, people are no longer confined to their own local cuisine, but love to taste the local specialty, taste foreign tools, so as to drink with ice cream and chocolate dessert on the fast increase.
cold drink shop is now very rapid development, the choice of a good brand to join the project investment can get a good income, cold drink shop to join, what kind of vision in general? Light seen above Xiaobian, trust everyone for the cold store market prospects have met, in the quality of the food, more and more people with fresh, healthy, health and green, is not really bad. It is also suitable for the international market on the ice cream giants have to abandon the low-end products, the trend of high-end investment products.